| Date Initiated by Firm | December 10, 2019 |
| Create Date | February 07, 2020 |
| Recall Status1 |
Terminated 3 on February 16, 2021 |
| Recall Number | Z-1107-2020 |
| Recall Event ID |
84439 |
| 510(K)Number | K923122 |
| Product Classification |
Enzyme linked immunoabsorbent assay, varicella-zoster - Product Code LFY
|
| Product | VIDAS Varicella Zoster IgG (VZG) antibody IVD, kit |
| Code Information |
US Model 30217-01 Lot 1007410330 and 1007393380 |
| FEI Number |
3002769706
|
Recalling Firm/ Manufacturer |
bioMerieux, Inc. 100 Rodolphe St Durham NC 27712-9402
|
| For Additional Information Contact | Anne St¿phanie GUIGNOT 919-620-2000 |
Manufacturer Reason for Recall | Two batches of VIDAS Varicella-Zoster IgG (VZG ref 30217) may yield an invalid calibration which may delay the patient's sample result or a valid calibration may lead to a false positive patient result. |
FDA Determined Cause 2 | Unknown/Undetermined by firm |
| Action | Users are instructed via customer letter to stop using the VIDAS VZG batches 1007410330 and 1007393380 and destroy the remaining products. |
| Quantity in Commerce | 1,218 US units total (726 US, 492 OUS) |
| Distribution | Distributed nationwide and 9 units to Biomerieux Canada. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = LFY
|